IP Library Granted Patent US 9,238,671
Granted Patent B2
US 9,238,671 · App. 13/979,346 · Granted Jan 19, 2016

Oligonucleotide replacement for di-tagged and directional libraries

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,671
App. No.
13/979,346
Granted
Jan 19, 2016
Kind
B2
Abstract

Transposomes and oligonucleotide replacement methods to make DNA libraries that have distinct 5′ and 3′ tags, and to make directional libraries that are enriched for a desired strand.

Claims (33)

1. A method for adding a tag to the double-stranded product of a tagmentation reaction, comprising the steps of:

(a) providing a double-stranded target nucleic acid and a transposome having a transposase with two transposon end sequences: a “transferred strand” and a “non-transferred strand”;

(b) allowing the transposome to fragment the target nucleic acid, whereby the transferred strand is covalently transferred to a first strand of a fragment, and the non-transferred strand remains hybridized to the transferred strand;

(c) removing the non-transferred strand from the transferred strand;

(d) providing a replacement oligonucleotide that comprises a tag sequence, to hybridize to the transferred strand; and

(e) ligating the replacement oligonucleotide to the second strand of the fragment;

thereby generating a tagmentation product having a transferred strand and a replacement oligonucleotide.

2. The method of claim 1 , wherein one strand of the target nucleic acid is chemically modified.

3. The method of claim 2 , wherein the chemical modification is conversion of cytosines to uracils.

4. The method of claim 2 , further comprising the step of

(f) enriching for a desired strand.

5. The method of claim 4 , wherein step (f) comprises treating the fragment with an enzyme that preferentially cleaves a nondesired strand of the fragment.

6. The method of claim 4 , wherein step (f) is performed using a template-dependent polymerase that is sensitive to chemical modifications.

7. The method of claim 1 , wherein the transposome comprises a Tn5 transposase.

8. The method of claim 1 , wherein the transposome comprises a Mu transposase.

9. The method of claim 1 , wherein the transferred strand comprises the ME sequence

SEQ ID NO: 1)

MRWTGTGHWKAVGARACAV

or

(SEQ ID NO: 2)

NSHBGHSHDDRNGAKACAN,

but excluding

(SEQ ID NO: 3)

AGATGTGTATAAGAGACAG.

10. The method of claim 9 , wherein the transferred strand further comprises a tag sequence.

11. The method of claim 1 , wherein the non-transferred strand comprises

(SEQ ID NO: 20)

BTGTYTCBTN 1-10

or

(SEQ ID NO: 21)

NTGTMTCNTN 0-10 .

12. The method of claim 1 , wherein the non-transferred strand is selected from the group consisting of SEQ ID NO:9, SEQ ID NO:10, SEQ ID NO:11, SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, and SEQ ID NO:18.

13. The method of claim 1 , wherein step (e) further comprises an extension step.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2013
From: GORYSHIN, IGOR YU; BAAS, BRADLEY; VAIDYANATHAN, RAMESH; MAFFITT, MARK
To: ILLUMINA, INC.
Reel/Frame 031175/0370 →